Y-mAbs Therapeutics Inc.

AI Score

0

Unlock

6.18
-0.01 (-0.16%)
At close: Jan 22, 2025, 3:59 PM
6.19
0.08%
After-hours Jan 22, 2025, 04:41 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -13.89 -2.21 -12.42 -16.78 -13.94 -13.52 -41.7 -46.85
PS Ratio 3.51 3.27 20.06 95.72 n/a n/a n/a n/a
PB Ratio 2.95 1.95 3.89 18.77 5.53 4.16 9.73 66.25
P/FCF Ratio -10.93 -2.81 -6.76 -21.73 -14.57 -14.11 -50.35 -71.56
P/OCF Ratio -10.93 -2.81 -6.83 -21.77 -14.96 -14.19 -50.35 -71.56
OCF/S Ratio -0.32 -1.16 -2.94 -4.4 n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.02 0.02 0.04 0.01 n/a n/a n/a
Quick Ratio 5.27 4.38 7.06 6.30 15.60 16.61 11.53 5.80
Current Ratio 5.52 4.61 7.26 6.26 15.60 16.61 11.53 5.80
Asset Turnover 0.66 0.46 0.16 0.16 n/a n/a n/a n/a
Interest Coverage n/a -125.25 -62.33 -200.56 -42.01 n/a n/a n/a
Return on Equity (ROE) -0.21 -0.88 -0.31 -1.12 -0.4 -0.31 -0.23 -1.41
Return on Assets (ROA) -0.17 -0.68 -0.26 -0.9 -0.36 -0.28 -0.21 -0.99
Return on Capital (ROIC) -0.24 -0.84 -0.62 -1.07 -0.41 -0.3 -0.23 -1.19
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 86.54% 88.41% 92.80% 89.38% n/a n/a n/a n/a
Net Profit Margin -25.26% -147.59% -161.46% -570.33% n/a n/a n/a n/a
Pretax Profit Margin -24.6% -146.43% -158.39% -575.12% n/a n/a n/a n/a
Operating Profit Margin -30.27% -145.27% -330.78% -578% n/a n/a n/a n/a
FCF Margin -32.11% -116.32% -296.65% -440.51% n/a n/a n/a n/a
EBITDA Margin -29.4% -145.14% -156.15% -576.09% n/a n/a n/a n/a